Literature DB >> 23549344

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

D A Abdulahad1, J Westra, E Reefman, E Zuidersma, J Bijzet, P C Limburg, C G M Kallenberg, M Bijl.   

Abstract

SUMMARY: Photosensitivity is characteristic of systemic lupus erythematosus (SLE). Upon ultraviolet B (UVB) exposure, patients develop inflammatory skin lesions in the vicinity of sunburn cells (SBCs). High mobility group box 1 (HMGB1) is released from apoptotic and activated cells and exerts inflammatory actions through ligation to its receptors.
METHODS: Eleven SLE patients and 10 healthy controls (HCs) were exposed to UVB. Skin biopsies were taken before and at one, three and 10 days after irradiation. Sections were stained for SBC, HMGB1, CD3, CD68, interferon-induced protein MxA and cleaved caspase 3. In vitro experiments with UVB-irradiated keratinocytes were also performed. Higher numbers of cells that had released HMGB1 were seen in the skin of SLE patients compared to HCs before and after irradiation. HMGB1-negative nuclei correlated with the presence of SBCs, and with the number of cleaved caspase 3 positive cells in lupus skin.
RESULTS: HMGB1 release is increased in the skin of SLE patients compared to HCs. Upon UVB exposure, HMGB1 release further increases in SLE patients and is related to the number of apoptotic cells. Our data suggest that HMGB1, probably released from apoptotic keratinocytes, contributes to the development of inflammatory lesions in the skin of SLE patients upon UVB exposure.

Entities:  

Keywords:  HMGB1; SLE; skin

Mesh:

Substances:

Year:  2013        PMID: 23549344     DOI: 10.1177/0961203313483377

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Lupus Skin Is Primed for IL-6 Inflammatory Responses through a Keratinocyte-Mediated Autocrine Type I Interferon Loop.

Authors:  Jasmine N Stannard; Tamra J Reed; Emily Myers; Lori Lowe; Mrinal K Sarkar; Xianying Xing; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Invest Dermatol       Date:  2016-09-16       Impact factor: 8.551

2.  Burn Injury Alters Epidermal Cholinergic Mediators and Increases HMGB1 and Caspase 3 in Autologous Donor Skin and Burn Margin.

Authors:  Casey J Holmes; Jennifer K Plichta; Richard L Gamelli; Katherine A Radek
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

Review 3.  Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target.

Authors:  Ruixuan You; Xinglan He; Zhuotong Zeng; Yi Zhan; Yangfan Xiao; Rong Xiao
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

4.  Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells.

Authors:  Jessica E Thaxton; Bei Liu; Pan Zheng; Yang Liu; Zihai Li
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

Review 5.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.

Authors:  Ju-Yang Jung; Chang-Hee Suh; Seonghyang Sohn; Jin-Young Nam; Hyoun-Ah Kim
Journal:  Clin Rheumatol       Date:  2016-05-26       Impact factor: 2.980

Review 8.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

Review 9.  The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases.

Authors:  Melinda Magna; David S Pisetsky
Journal:  Mol Med       Date:  2014-03-24       Impact factor: 6.354

10.  Expression and Significance of High-Mobility Group Protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in Knee Osteoarthritis.

Authors:  Xue-Hui Sun; Ying Liu; Yun Han; Jian Wang
Journal:  Med Sci Monit       Date:  2016-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.